These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 24770722)
1. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer. Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Jeon HS; Lee WK; Kim JG Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S634-9. PubMed ID: 24770722 [TBL] [Abstract][Full Text] [Related]
2. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004 [TBL] [Abstract][Full Text] [Related]
3. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer. Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer. Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes. Keshavarz P; Inoue H; Nakamura N; Yoshikawa T; Tanahashi T; Itakura M Mol Genet Metab; 2008 Feb; 93(2):200-9. PubMed ID: 17950019 [TBL] [Abstract][Full Text] [Related]
6. Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer. Chen M; Jiang B; He B; Tang M; Wang P; Chen L; Lu J; Lu P BMC Cancer; 2018 Sep; 18(1):923. PubMed ID: 30253744 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253 [TBL] [Abstract][Full Text] [Related]
8. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK Nutr Cancer; 2011 Nov; 63(8):1226-34. PubMed ID: 21999454 [TBL] [Abstract][Full Text] [Related]
9. IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Kim JG; Chae YS; Sohn SK; Moon JH; Kang BW; Park JY; Jeon SW; Lee MH; Lim KH; Choi GS; Jun SH Ann Oncol; 2010 Mar; 21(3):525-529. PubMed ID: 19759184 [TBL] [Abstract][Full Text] [Related]
10. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer. Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514 [TBL] [Abstract][Full Text] [Related]
11. Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population. Song HR; Kim HN; Kweon SS; Choi JS; Shim HJ; Cho SH; Chung IJ; Park YK; Kim SH; Choi YD; Joo KW; Shin MH Mol Carcinog; 2013 Nov; 52 Suppl 1():E155-60. PubMed ID: 23861218 [TBL] [Abstract][Full Text] [Related]
13. Examining the polymorphisms in the hypoxia pathway genes in relation to outcome in colorectal cancer. Haja Mohideen AM; Hyde A; Squires J; Wang J; Dicks E; Younghusband B; Parfrey P; Green R; Savas S PLoS One; 2014; 9(11):e113513. PubMed ID: 25405996 [TBL] [Abstract][Full Text] [Related]
14. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer. Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827 [TBL] [Abstract][Full Text] [Related]
15. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer. He TY; Tsai LH; Huang CC; Chou MC; Lee H Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Lee SY; Jin CC; Choi JE; Hong MJ; Jung DK; Do SK; Baek SA; Kang HJ; Kang HG; Choi SH; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Lee YM; Lee IK; Jheon S; Park JY Sci Rep; 2016 Oct; 6():35603. PubMed ID: 27767175 [TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival. Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395 [TBL] [Abstract][Full Text] [Related]
18. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling. Matthew EM; Yang Z; Peri S; Andrake M; Dunbrack R; Ross E; El-Deiry WS Neoplasia; 2018 Mar; 20(3):244-255. PubMed ID: 29448085 [TBL] [Abstract][Full Text] [Related]
19. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib. Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma. Byeon SJ; Han N; Choi J; Kim MA; Kim WH J Surg Oncol; 2014 Jun; 109(8):812-7. PubMed ID: 24615476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]